A poster presented at the American Diabetes Association (ADA) 2026 Scientific Sessions by the Pharmacy Technician Certification Examination board (PTCE) underscores a persistent challenge in type 2 diabetes management: clinical inertia — the failure to advance therapy when clinical endpoints indicate a need for change. The research positions targeted continuing education for pharmacists as a measurable lever for closing that gap and reinforcing evidence-based care protocols.
Clinical inertia in type 2 diabetes is well-documented, with studies consistently showing that patients remain on suboptimal regimens longer than guidelines recommend. PTCE's findings suggest that structured, pharmacist-focused educational interventions can shift prescribing and counseling behaviors, equipping practitioners to proactively advocate for therapeutic escalation — including appropriate use of newer cardiometabolic agents — at the point of dispensing and consultation. While the poster abstract does not publish specific numeric outcomes, the research framing aligns with a growing body of peer-reviewed literature linking pharmacist-led intervention to improved HbA1c trajectories and medication adherence rates.
The functional foods and nutraceutical channel has a direct stake in this clinical conversation. Ingredients including berberine, chromium picolinate, alpha-lipoic acid, and resistant starch are increasingly positioned alongside — or as adjuncts to — standard-of-care diabetes therapy, with structure-function claims targeting glycemic support and insulin sensitivity. As pharmacists become more active in diabetes care coordination, their nutritional literacy and familiarity with evidence-backed supplements will influence which finished formulations reach patients managing blood glucose. Operators in the glycemic health and metabolic wellness segments should treat pharmacist education initiatives as a meaningful market-access variable.
The broader context reinforces urgency. The global diabetes management market is under significant transformation as GLP-1 receptor agonists reshape prescribing norms and patient expectations simultaneously. Nutraceutical brands that can provide pharmacists with clinical-grade substantiation — peer-reviewed data, standardized extract specifications, and clear mg/serving dosing — are better positioned for shelf placement in pharmacy retail and integration into pharmacist counseling scripts. Co-manufacturing partners serving the pharmacy channel should anticipate demand for cleaner dossiers and GRAS-aligned ingredient sourcing.
For trade buyers and brand developers, the PTCE research is a useful signal: the pharmacist is an increasingly influential gatekeeper in the diabetes care pathway, and educational programming that elevates their clinical confidence has downstream implications for supplement and functional food adoption. Engagement with continuing education platforms and point-of-care materials represents an underleveraged channel strategy for brands competing in glycemic and metabolic health categories.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.